Skip to main content
SpringerLink
Log in

Dépistage des tumeurs colorectales par les tests moléculaires

  • Chapter
Le dépistage du cancer colorectal

Part of the book series: Dépistage et cancer ((DC))

  • 251 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Ahlquist DA (1997) Fecal occult blood testing for colorectal cancer. Can we afford to do this? Gastroenterol Clin North Am 26: 41–55

    Article  PubMed  CAS  Google Scholar 

  2. Ahlquist DA, Skoletsky JE, Boynton KA et al. (2000) Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119: 1219–27

    Article  PubMed  CAS  Google Scholar 

  3. Frank JW (1985) Occult-blood screening for colorectal carcinoma: the yield and the costs. Am J Prev Med 1: 18–24

    PubMed  CAS  Google Scholar 

  4. Lieberman DA, Weiss DG (2001) One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 345: 555–60

    Article  PubMed  CAS  Google Scholar 

  5. Loktionov A, O’Neill IK, Silvester KR et al. (1998) Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer. Clin Cancer Res 4: 337–342

    PubMed  CAS  Google Scholar 

  6. Selby JV, Fireman BH, Lundstrom RJ et al. (1996) Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. N Engl J Med 335: 1888–96

    Article  PubMed  CAS  Google Scholar 

  7. Mandel JS, Bond JH, Church TR et al. (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328: 1365–71

    Article  PubMed  CAS  Google Scholar 

  8. Kronborg O, Fenger C, Olsen J et al. (1989) Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol 24: 599–606

    PubMed  CAS  Google Scholar 

  9. Hardcastle JD, Chamberlain JO, Robinson MH et al. (1996) Randomised controlled trial of fæcal-occult-blood screening for colorectal cancer. Lancet 348: 1472–7

    Article  PubMed  CAS  Google Scholar 

  10. Kewenter J, Brevinge H, Engaras B et al. (1994) Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 29: 468–73

    PubMed  CAS  Google Scholar 

  11. Faivre J, Dancourt V, Lejeune C et al. (2004) Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 126: 1674–80

    Article  PubMed  Google Scholar 

  12. Newcomb PA, Norfleet RG, Storer BE et al. (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84: 1572–5

    PubMed  CAS  Google Scholar 

  13. Traverso G, Shuber A, Levin B et al. (2002) Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 346: 311–20

    Article  PubMed  CAS  Google Scholar 

  14. Albaugh GP, Iyengar V, Lohani A et al. (1992) Isolation of exfoliated colonic epithelial cells, a novel, non-invasive approach to the study of cellular markers. Int J Cancer 52: 347–50

    PubMed  CAS  Google Scholar 

  15. Limburg PJ, Ahlquist DA, Gilbert JA et al. (2000) Immunodiscrimination of colorectal neoplasia using MUC1 antibodies: discrepant findings in tissue versus stool. Dig Dis Sci 45: 494–9

    Article  PubMed  CAS  Google Scholar 

  16. Rosenberg IL, Giles GR (1977) The value of colonic exfoliative cytology in the diagnosis of carcinoma of the large intestine. Dis Colon Rectum 20: 1–10

    PubMed  CAS  Google Scholar 

  17. Boland CR, Sato J, Saito K et al. (1998) Genetic instability and chromosomal aberrations in colorectal cancer: a review of the current models. Cancer Detect Prev 22: 377–82

    Article  PubMed  CAS  Google Scholar 

  18. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759–67

    Article  PubMed  CAS  Google Scholar 

  19. Osborn NK, Ahlquist DA (2005) Stool screening for colorectal cancer: molecular approaches. Gastroenterology 128: 192–206

    Article  PubMed  CAS  Google Scholar 

  20. Imperiale TF, Ransohoff DF, Itzkowitz SH et al. (2004) Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351: 2704–14

    Article  PubMed  CAS  Google Scholar 

  21. Syngal S, Chung D, Willet C et al. (2002) Stool DNA analysis for the detection and follow-up of colorectal cancer (CRC) and advanced adenomas (AA): sensitivity in a prospective series. Gastroenterology 97: 332

    Google Scholar 

  22. Sidransky D, Tokino T, Hamilton SR et al. (1992) Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256:102–5

    PubMed  CAS  Google Scholar 

  23. Frigola J, Sole X, Paz MF et al. (2005) Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Hum Mol Genet 14: 319–326

    Article  PubMed  CAS  Google Scholar 

  24. Lenhard K, Bommer GT, Asutay S et al. (2005) Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. Clin Gastroenterol Hepatol 3: 142–9

    Article  PubMed  CAS  Google Scholar 

  25. Muller HM, Oberwalder M, Fiegl H et al. (2004) Methylation changes in fæcal DNA: a marker for colorectal cancer screening? Lancet 363: 1283–5

    Article  PubMed  CAS  Google Scholar 

  26. Chen WD, Han ZJ, Skoletsky J et al. (2005) Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 97: 1124–32

    Article  PubMed  CAS  Google Scholar 

  27. Anacleto C, Rossi B, Lopes A et al. (2005) Development and application of a multiplex PCR procedure for the detection of DNA methylation in colorectal cancer. Oncol Rep 13: 325–8

    PubMed  CAS  Google Scholar 

  28. Schatz P, Dietrich D, Schuster M (2004) Rapid analysis of CpG methylation patterns using RNase T1 cleavage and MALDI-TOF. Nucleic Acids Res 32: e167

    Article  PubMed  CAS  Google Scholar 

  29. Davidson LA, Lupton JR, Miskovsky E et al. (2003) Quantification of human intestinal gene expression profiles using exfoliated colonocytes: a pilot study. Biomarkers 8: 51–61

    Article  PubMed  CAS  Google Scholar 

  30. Melissourgos N, Kastrinakis NG, Davilas I et al. (2003) Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker. Urology 62: 362–7

    Article  PubMed  CAS  Google Scholar 

  31. Niiyama H, Mizumoto K, Sato N et al. (2001) Quantitative analysis of hTERT mRNA expression in colorectal cancer. Am J Gastroenterol 96: 1895–900

    Article  PubMed  CAS  Google Scholar 

  32. Cruz-Correa M, Cui H, Giardiello FM et al. (2004) Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology 126: 964–70

    Article  PubMed  CAS  Google Scholar 

  33. Fliss MS, Usadel H, Caballero OL et al. (2000) Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287: 2017–9

    Article  PubMed  CAS  Google Scholar 

  34. Polyak K, Li Y, Zhu H et al. (1998) Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20: 291–3

    Article  PubMed  CAS  Google Scholar 

  35. Lievre A, Chapusot C, Bouvier AM et al. (2005) Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol 23: 3517–25

    Article  PubMed  CAS  Google Scholar 

  36. Song K, Fendrick AM, Ladabaum U (2004) Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. Gastroenterology 126: 1270–9

    Article  PubMed  Google Scholar 

  37. Hardt PD, Toepler M, Ngoumou B et al. (2003) Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls. Anticancer Res 23: 851–3

    PubMed  CAS  Google Scholar 

  38. Kim Y, Lee S, Park S et al. (2003) Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen. Ann Clin Lab Sci 33: 32–8

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’hépato-gastro-entérologie, CHU Henri-Mondor, 51, avenue du Maréchal de Lattre de Tassigny, 94010, Créteil, France

    I. Sobhani & M. Abolhassani

Authors
  1. I. Sobhani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Abolhassani
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Sobhani, I., Abolhassani, M. (2006). Dépistage des tumeurs colorectales par les tests moléculaires. In: Le dépistage du cancer colorectal. Dépistage et cancer. Springer, Paris. https://doi.org/10.1007/2-287-32803-3_4

Download citation

  • DOI: https://doi.org/10.1007/2-287-32803-3_4

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-32802-2

  • Online ISBN: 978-2-287-32803-9

Publish with us

Policies and ethics

Search

Navigation